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The National Cancer Registry is now in its 27th year of data collection, having begun registration of cancers and related 
tumours in 1994. Over this time, the registry has provided surveillance of trends in cancer incidence, treatment, 
survival, and prevalence, along with associated clinical and demographic aspects of the patient population. This report 
on the burden of cancer attributable to a selection of modifiable risk factors in Ireland will aid decisions on priorities 
for cancer control initiatives. This is the first time that the impact of multiple modifiable factors on cancer risk has 
been assessed in Ireland. 
 
The key finding presented in this report is that in Ireland, in 2016 alone there were about 6,240 cancer cases that were 
attributable to the 11 modifiable risk factors chosen for this analysis. The report indicates that just among these 11 
factors, 29% of cancer incidence in Ireland was potentially preventable, and notes that this is a conservative estimate. 
13% of cancer incidence was attributable to smoking. Over a ten-year period ending in 2035, it is estimated that three 
of these factors alone, smoking, overweight and obesity and alcohol intake, will be responsible for 66,000 cancer cases. 
 
There are some important factors to consider when interpreting these results. Due to limitations in data availability, 
certain modifiable risk factors, such as occupation related risks and everyday sun exposure, were not included in this 
report and therefore the preventable proportion of cancer incidence in Ireland is likely to be considerably higher. 
Where these additional risk factors were included, for example studies in the UK and US, the proportion attributable 
to modifiable risks were as high as 38% and 42% respectively. 
 
The approach to this work is based on an established, high-stringency methodology and provides largely conservative 
estimates for the number of cancers attributable to risk factors for the whole population. It allows for international 
comparisons and will provide evidence to inform debate on cancer prevention in Ireland. The stringency of the 
methods employed means that, in some cases, the figures arrived at may also be lower than other equivalent analyses. 
This work is intended to be interpreted at a population level and is not designed to provide an assessment of cancer 
risk in an individual which is highly complex and relating to many factors, such as length of exposure to the risk factors, 
interactions of different behaviours, as well as demographic characteristics, individual genetics and other protective 
behaviours, as well as chance. Individuals who are concerned about their cancer risk should seek the advice of a 
medical professional. 
 
This report builds on the previous NCRI investigation into projections of cancer incidence and reinforces the important 
role that cancer prevention strategies will have in ensuring that projected increases in cancer incidence are not 
realised. It is recommended that the findings in this report are used for future health related policy planning.  
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REPORT AT A GLANCE 
Who are we, and what  
do we do? 
 
The National Cancer Registry of 
Ireland (NCRI) works on behalf of the 
Department of Health and collects 
information from all hospitals in 
Ireland on the number of persons 
diagnosed with cancer and the types 
of cancer they have. 
NCRI also follows up the numbers 
dying from their cancer or from other 
causes. This allows the monitoring of 
trends and outcomes in different 
cancer types, which in turn assists 
with the planning and management of 
services. All the patient’s personal and 
private details are removed before 
summaries of this information are 
made available to the public and 
health professionals through our 
annual cancer report and other reports 
on our website. 
How are the numbers calculated? 
 
NCRI data on the number of cancer cases in 2016 
was utilised for this report. Data were also collected 
from a variety of sources to determine both the 
extent to which the Irish population are exposed to 
each risk factor and the likelihood of being 
diagnosed from cancer as a result of the exposure. 
A modifiable risk factor is a behaviour or exposure 
that can potentially be changed, resulting in a 
change in risk of disease. In relation to cancer, these 
include smoking, infection, being overweight or 
obese, alcohol intake, sunburn, sunbed history, 
radiation, processed meat intake, hormonal 
replacement therapy, oral contraceptive, lack of 
physical activity, and exposure to fine particulate air 
pollution. 
All of this information was inputted to formulae to 
calculate the percentages and numbers of cancer 
cases attributable to each risk factor. 
In addition, the number of cancer cases associated 
with smoking, overweight and obesity, and alcohol 
intake that would occur in 2035 were estimated 
depending on whether current estimated attributable 
risks remained the same or if there were changes in 
exposure to the risk factors. 
 
What have we found? 
In 2016, 3/10 of all invasive cancers (i.e. excluding non-melanoma skin cancer (NMSC)) were 
attributable specifically to the sum of the 11 modifiable risk factors examined. This suggests that at 
least 6,240 cancer cases were potentially preventable in Ireland in 2016, and the true figure is likely 
to be higher. With 2,780 diagnoses or about 1/8 of all invasive cancer cases, smoking (including 
passive smoking) was associated with the highest attributable burden. By 2035, assuming these 
risk estimates continue to apply, it is estimated that 4,660 cases of invasive cancer per year will be 
attributable to smoking, 1,790 cancer cases will be attributable to overweight and obesity, and 850 
cancer cases will be attributable to alcohol intake. It is essential that measures are undertaken and 
continued, especially at a population level, to ensure that possible increases in cancer cases in the 
future do not become a reality. It is recommended that the findings in this report are used for future 
health-related policy planning. 
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The proportion of primary cancer incidence attributable to 
modifiable risk factors in Ireland. 
Cancer cases attributable to 
modifiable risk factors, 2016. 
 The population attributable fractions (PAFs) are 
interpreted as the proportion of cases that would be 
prevented if exposure to a causal factor in the entire 
population was adjusted to the level of the 
reference category (i.e. ideal exposure). 
 Cancer type and risk factor combinations were 
included using stringent definitions by the 
International Agency for Research on Cancer (IARC) 
or World Cancer Research Fund (WCRF) that there 
was “sufficient” (IARC) or “convincing” (WCRF) 
evidence of a causal association with a specific 
cancer type. It is important to consider that these 
classifications describe the level of scientific 
evidence that a risk factor is linked to a cancer, but 
not how much cancer they cause. 
 This report estimates that in 2016, 29.3% of all 
cancer cases (excluding non-melanoma skin cancer 
(NMSC)) were attributable to the 11 modifiable 
specific risk factors examined (see list in Table 1).  
 6,238 cancer cases (out of a total of 21,315) were 
potentially preventable in Ireland in 2016.  
 This is a conservative estimate for a number of 
reasons. For example, risks associated with 
occupation were not accounted for here and may be 
examined in a further analysis. In the UK, 3.8% of 
cancer cases were attributable to occupation. Due to 
a lack of data on sun exposure behaviours among 
the population in Ireland, everyday exposure to 
ultra-violet radiation (UVR) was not included either; 
only whether a person had ever been sunburned or 
used a sunbed (where Irish data is available). 
 Smoking, overweight and obesity, and infections 
were the top three risk factors in Ireland: 
 Smoking (including passive smoking in the home) 
was the risk factor with the highest attributable 
cases of all cancer (excluding NMSC) at 13%, 
accounting for 2,779 cases. 
 5% of cancer cases (excluding NMSC) were 
attributable to being overweight or obese, 
equating to 1,061 cancer cases in Ireland in 2016. 
 A number of carcinogenic infection types (HPV, H. 
pylori, EBV, Hep B, Hep C and HIV) were grouped 
together; 3.6% of cancer (excluding NMSC) 
incidence was attributable to these infections. 
 PAFs and attributable cases of cancer by risk factor 
are summarised in Table 1.  
 Lung cancer had the highest number of cases 
attributable to modifiable risk factors in both males 
and females, followed by colon cancer in males and 
breast cancer in females. 
 PAFs and attributable cancer cases by cancer type in 
males and females are presented in Tables 2 and 3 
respectively. 
Projections of cancer cases 
attributable to modifiable risk 
factors to 2035. 
 Cancer cases (excluding NMSC) attributable to 
smoking (excluding passive smoking), overweight 
and obesity, and alcohol intake were modelled to 
2035 on the assumption that current PAFs remain 
the same (i.e. that only population numbers and 
age-structure change):  
 In 2035, it is estimated that: 
  4,662 cancer cases will be attributable to 
smoking. 
TECHNICAL SUMMARY 
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 1,788 cancer cases will be attributable to 
overweight and obesity. 
 851 cancer cases will be attributable to alcohol 
intake. 
 Over a 10-year period ending in 2035, it is estimated 
that a cumulative total of 66,343 cancer cases will be 
attributable to smoking, overweight and obesity and 
alcohol intake. 
 In addition, projections were calculated assuming a 
variety of different scenarios related to changes in 
the prevalence of risk factors — for example, if the 
prevalence of current smokers were reduced from 
29% to 5%. See pages 33-37 for further details. 
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 Modifiable risk factors were selected for this 
investigation if classified by the International Agency 
for Research on Cancer (IARC) or World Cancer 
Research Fund (WCRF) as having “sufficient” (IARC) 
or “convincing” (WCRF) evidence of a causal 
association. 
 The PAF is interpreted as the proportion of cases 
that would be prevented if exposure to a causal 
factor in the entire population was adjusted to the 
level of the reference category (i.e. the level of ideal 
exposure to a risk factor, usually zero). 
 Calculating PAF as percentages and attributable 
cases requires information on the population 
prevalence of each risk factor, the relative risk 
associated with each risk factor, and the incidence 
of each cancer type in the population. 
 Cancer incidence data for 2016 was obtained for the 
Irish population from the NCRI which records all 
incident cancers in Ireland. All age groups were 
included in the analysis. Results were calculated for 
males, females and all persons. For each potential 
risk factor, literature was reviewed to identify the 
most suitable Irish-based population prevalence 
data, preferably nationally representative surveys. 
 When calculating PAFs, the amount of time between 
exposure to the risk factor and cancer outcome 
(time lag) was considered. This can be difficult to 
determine as the amount of time varies depending 
on the risk factor and the cancer site. However, 
based on methodology used by similar national 
studies in other jurisdictions, a 10-year lag was 
applied. When exposure of the Irish population to 
risk factors was not available for 2006, data from the 
nearest timeframe was employed in the analyses. 
See methodology annex for further details. 
 The UK’s recently systematically searched and 
published relative risks were obtained. More recent 
published literature was then reviewed to  
 
determine if there were any more recent meta-
analyses available. 
 It is important to note the difference between 
attributable risk and relative risk, which are 
mentioned throughout the report. Relative risk 
refers to magnitude of an association between 
exposure and disease, based on the incidence of 
disease in the exposed group relative to the 
unexposed group. Attributable risk refers to the 
absolute difference in incidence between an 
exposed and unexposed group. In some instances, a 
high relative risk may translate to a small 
attributable risk. 
 The formulae with which the PAFs are calculated are 
given in the methodology annex. 
 PAFs for all risk factors combined, for each cancer 
type, were obtained by first applying the first 
relevant PAF in the sequence to the total number of 
observed cases, to obtain the number of cases 
attributable to that factor only. Resultant figures 
were then summed across all relevant cancers for a 
given risk factor. 
 Each subsequent PAF in the sequence was applied 
only to the number of observed cases not yet 
explained by the risk factors earlier in the sequence.  
This approach ensures that the overall number of 
attributable cases is not over-estimated, but has a 
significant bearing on the measurement of the 
number of cases attributed to each risk factor and 
cancer type as a number of cases are removed from 
the calculation for each analysis.  This results in the 
calculation of a lower number of preventable cases 
for those PAFs applied later in the sequence, i.e. 
PAFs of a lower value. However, use of a different 
sequence does not change the overall result in terms 
of the total number or proportion of cancer cases 
attributable to the risk factors in combination. 
METHODOLOGY 
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 Models were developed to project all cancer cases 
(excluding NMSC) to 2035 that are attributable to 
the following major risk factors; smoking (excluding 
passive smoking), overweight and obesity, and 
alcohol intake. In order to calculate the cancer cases 
attributable to each risk factor, we applied the PAF 
calculated and reported for 2006 exposure for males 
and females to projected incidence. Projected 
incidence assumed that recent age-specific 
incidence rates applied to future populations. 
 Various target and trend scenarios were also applied 
to these projection models. 
 Further details on the methodology are presented in 
the methodology annex. 
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 Smoking is the biggest cause of cancer across the 
world and causes 15 different types of cancers (see 
Figure 1.1) (1). 
 
 Cigarettes contain thousands of compounds, 
including over 60 carcinogens, which enter our 
bloodstream and can affect the entire body (2).  
 Current smoking, being an ex-smoker and exposure 
to smoking in the home was included in this analysis, 
see methodology annex for further details. 
 The 2007 SLAN survey reported that in Ireland, 48% 
of people had smoked at some point in their lives, 
with 29% reporting being current smokers (3). 
 Passive smoking (the involuntary inhaling of smoke 
from other people’s cigarettes) is also a risk factor 
for lung cancer and was therefore considered in this 
analysis. 59% of people reported smoking was not 
allowed anywhere in their home (3), although 
figures on passive smoking outside the home were 
not available.  
 
 
 There are different levels of risk associated with 
being a current or former smoker, or being exposed 
to second-hand smoke and the risk also varies 
depending on the cancer site. The lungs are the most 
at risk of developing cancer with a current smoker 
being 9 times more likely to develop lung cancer 
compared to someone who has never smoked (4).  
 This risk is reduced for former smokers to less than 
4 times that of never smokers (4). Stopping smoking 
completely is recommended. 
 Using our conservative analyses, at least 76% of lung 
cancers in Ireland are attributable to smoking 
(including passive smoking in the home), with the 
larynx and bladder being the cancer sites with the 
next highest percentages attributable to smoking 
(Figure 1.2).   
 
 Overall, smoking (including passive smoking) is the 
biggest contributor to cancer in Ireland and is 
responsible for 13% of all cancer (excluding NMSC). 
The estimated total of cancer cases attributable to 
smoking in Ireland in 2016 was 2,779, and a similar 
figure is likely to apply currently. Figure 1.3 presents 
the difference between male and female cancer 
incidence related to smoking.  
RISK FACTOR 1. SMOKING 
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 These estimates are likely to be conservative as 
although they account for passive smoking in the 
home, they do not account for other regular passive 
smoke exposures (i.e. outside the home), such as in 
vehicles and public spaces. Additionally, smoking 
may interact with other risk factors to further 
increase cancer risk. For example, in lung cancer 
there exists a synergistic interaction between radon 
exposure and smoking which is not accounted for 
here. 
 Projections of avoidable incidence of cancer as a 
result of tobacco smoking are discussed in 
projections section (page 33).  
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How do these figures compare? 
The PAFs for smoking and cancer incidence in 
Ireland are similar to those reported in Australia 
and the UK at 13.4% and 15.1% respectively (5, 6). 
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  According to IARC, having a body mass index (BMI) 
of 25 kg/m3 or more —defined as being overweight 
(25-29.9 kg/m3) or obese (≥30 kg/m3) — is a risk 
factor for developing certain forms of cancer (1). 
 Keeping a moderate weight reduces the risk of 13 
different types of cancer; those associated with 
being overweight or obese are shown in Figure 2.1.  
 There are a number of ways in which being 
overweight or obese is thought to contribute to risk 
of developing of cancer; the major mechanisms 
include changes in sex hormone metabolism, 
increased insulin levels and adipokine 
pathophysiology, as well as systemic inflammatory 
changes  (2). 
 Data on the rates of overweight and obesity in 
Ireland was reported in 2007 SLAN report and used 
in this analysis. This report found that, of samples of 
respondents that were independently measured, 
30% of men and 40% of women had BMIs within the 
healthy range (3). 45% of men and 33% of women 
were reported to be overweight, while 24% of men 
and 26% of women were reported to obese. 
 
 In 2019, the latest data from the national 
longitudinal study “Growing Up in Ireland” showed 
that 15% of five-year olds were overweight and 5% 
were obese (5). This suggests that overweight and 
obesity may remain a health challenge in Ireland in 
the future. 
 The level of risk associated with BMI is different 
depending on whether the person is overweight or 
obese and which cancer type is involved. The cancer 
sites associated with the highest relative risk as a 
result of being overweight or obese are the 
oesophagus (adenocarcinoma type only) and the 
uterus. It should be noted that although these 
cancers have the highest relative risk, due to lower 
incidence they do not contribute as impactfully to 
numbers at the population level. 
 In Ireland, overweight and obesity contributes the 
highest proportion of attributable cases for cancer in 
the kidney, liver and gallbladder (Figure 2.2). Of 
these, cancer of the kidney had the highest number 
of cases (155) attributable to a high BMI in 2016. 
However, this was exceeded by cancer of the colon 
that were attributable to overweight and obesity at 
182 cases (lower PAF, 11% but a more common 
cancer).  
RISK FACTOR 2. OVERWEIGHT AND OBESITY 
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 Overall, 5.0% of all cancer cases (excluding NMSC) 
were attributable to a high BMI in Ireland in 2016. In 
total, an estimated 1,061 cancer cases were 
attributable to being overweight or obese in Ireland 
in 2016, and a similar number is likely to currently 
apply. See Figure 2.3 for comparisons between male 
and female cases. 
 Projections of cancer cases (all cancer excluding 
NMSC) to 2035 attributable to a high BMI are 
reported in the projections section (page 33).  
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How do these figures compare? 
The PAFs for overweight and obesity and cancer 
incidence in Ireland are similar to those reported 
previously in Ireland (4.5%), as well as in France 
and the UK at 5.4% and 6.3% respectively (6, 7, 8).  
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 According to IARC, infection with specific types of 
bacteria and viruses is defined as a risk factor for 
developing cancer (1).  
 These biological agents include hepatitis virus B 
(Hep-B) and C (Hep-C), Epstein-Barr virus (EBV), 
human immunodeficiency virus (HIV), human 
papillomavirus (HPV), Kaposi Sarcoma Herpesvirus 
(KSHV) and Helicobacter pylori (H. pylori).  
 The 14 cancer types that these biological agents are 
associated with are shown in Figure 3.1.  
 The ways in which these bacteria and viruses act as 
carcinogens have yet to be fully determined, and 
vary depending on the type. However, it is known 
that they can disrupt signalling that normally 
regulates cell growth and proliferation. They can 
also weaken the immune system and cause chronic 
inflammation, which can lead to cancer (1). 
 The Health Protection Surveillance Centre (HPSC) 
reports on the prevalence of many infection types in 
the Irish population. However, due to the absence of 
Irish information, data from Northern Ireland 
needed to be used in the case of H. pylori, and  
 
pre-calculated PAFs were used to calculate 
incidence attributable to EBV, HPV and KSHV. See 
methodology annex for further details. 
 There is a wide range in the level of risk associated 
with each infection and cancer type combination; for 
example, Hep-C is associated with a risk of non-
Hodgkin lymphoma 2 times higher and a risk of liver 
cancer almost 24 times higher in those exposed 
compared to non-exposed. Further information on 
risk factors related to infection is presented in the 
methodology annex. 
 In Ireland, HPV, H. pylori and EBV are the top 3 
infection types in terms of the percentage of all 
cancers (excluding NMSC) attributable to specific 
infectious agents (Figure 3.2). 397 cancers (exc 
NMSC) were attributable to HPV alone in 2016.  
 
 In terms of infection and specific cancer types, 257 
cervical cancers were attributable to HPV while 208 
stomach cancer (non-cardia) cases were attributable 
to H. pylori in 2016. See Figure 3.3 for the PAF for 
each infection type and cancer site combination. 
RISK FACTOR 3. INFECTIONS 
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 Overall, these infections are responsible for 3.6% of 
all cancer (excluding NMSC). The estimated total of 
cancer cases attributable to infections in Ireland in 
2016 was 766. See Figure 3.4 for comparisons of 
male and female cases. 
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How do these figures compare? 
The PAFs for infection and cancer incidence are 
similar to, but slightly higher than, those reported 
in France and the UK, at 4.0% and 3.6% 
respectively (2, 3). 
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 Both IARC and WCRF state there is sufficent or 
convincing evidence of a causal association 
between alcohol intake and developing some 
specific forms of cancer (1, 2). 
 Limiting alcohol intake reduces the risk of 7 different 
types of cancer; those associated with alcohol intake 
are shown in Figure 4.1.   
 
 The mechanisms through which alcohol intake 
increases cancer risk are not yet well defined but 
likely to include genotoxic effects, increased 
oestrogen, cellular stress, changes in folate 
metabolism and inflammation (3). 
 National Adult Nutrition Survey (NANS) data on 
alcohol intake was categorised into 4 groups: no 
alcohol, light, moderate, or heavy intake (see 
methodology). 86% of the adult population were 
alcohol consumers. 45% of men and 23% of women 
were moderate alcohol consumers, while 5% of men 
and 0.5% of women were heavy alcohol consumers 
(4). 
 The NANS report highlighted that the Department of 
Health has recommended that men consume no  
 
more than 17 Irish ‘standard drinks’ and women no 
more than 11 per week. Among Irish alcohol 
consumers aged 18-64 years, 29% of men and 24% 
of women report consuming higher than the 
maximum recommend weekly alcohol intake (4). 
 The level of risk associated with alcohol intake and 
cancer types is different depending on the amount 
of alcohol consumed and which cancer type is 
involved. For example, compared with a non-alcohol 
consumer, a person with light alcohol intake has a 
1.3 fold increased risk of a specific type of 
oesophageal cancer (squamous cell carcinoma 
[SCC]), and moderate and heavy consumers are 2.6 
and 5.5 times more likely to develop oesophageal 
SCC, respectively. A heavy alcohol consumer is also 
5 times more likely to develop pharyngeal and oral 
cavity cancer. See methodology for further 
breakdown.  
 In Ireland, of the cancers defined as alcohol-related 
in this report, those with the highest proportion 
attributable to alcohol intake were cancers in the 
pharynx, oral cavity, and larynx (Figure 4.2). A 
smaller proportion (7.5%) of female breast cancer is 
attributable to alcohol intake but this translates to 
a large number (223) of cases.  
RISK FACTOR 4. ALCOHOL INTAKE 
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 Overall, 2.4% of all cancer (excluding NMSC) was 
attributable to alcohol intake (as a single factor) in 
Ireland in 2016. The estimated total of cancer cases 
attributable to drinking alcohol in Ireland in 2016 
was 506, and a similar figure is likely to apply 
currently. See Figure 4.3 for differences between 
male and female incidence. 
 In 2013, Laffoy et al. published estimates of cancer 
incidence due to alcohol intake in Ireland and 
estimated higher PAFs; 4.7% in males and 4.2% in 
females (7). The differences between the PAFs 
reported here and previous Irish estimates are 
explained by methodological differences. For 
example, Laffoy et al. used SLAN data, adjusted for 
self-reporting, and estimates of relative risks based 
on earlier studies. In this analysis, NANS data and 
updated relative risks based on a 2015 meta-analysis 
were applied. Differences in the cancer site inclusion 
criteria between the two studies also contribute, but 
to a lesser extent, to differences.  
 Alcohol may interact with other risk factors to 
further increase cancer risk, for example there exists 
a synergistic interaction between alcohol intake with 
infections and smoking which is not accounted for 
here (1). 
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How do these figures compare? 
The PAFs for alcohol intake and cancer incidence in 
Ireland are similar to those reported by Australia 
and the UK, 2.8% and 3.3% respectively (5,6). They 
are lower than figures previously reported in 
Ireland as 4.7% in males and 4.2% in females, due 
to methodological differences (see text) (7). 
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  IARC state there is sufficent evidence of a causal 
association between exposure to solar radiation, as 
well as ultraviolet radiation-emitting tanning 
devices, and developing melanoma skin cancer (1). 
  This report focuses on the fraction of cancer 
attributable to sunburn history (at least single 
episode) and sunbed usage. It does not include the 
fraction attributable to everyday sun exposure due 
to lack of fuller data on Irish sun-exposure 
behaviours. Given the high prevalence of cancers 
associated with excess sun exposure in Ireland, 
there is a need for further analysis to be undertaken 
to establish a complete picture of the impact of sun 
exposure. 
 
 
 Excessive exposure to solar radiation can induce 
DNA damage in the skin. Over time, skin cancer may 
develop due to a build-up of this damage that causes 
the cells to start growing out of control (1). 
 There is limited data available on sun-exposure 
behaviours of the Irish population. Routine 
monitoring of sun exposure is important and would 
help determine the risk of cancer attributable to 
everyday sun exposure.  
 Surveys from Northern Ireland reported that 40% of 
people were never sunburned, and this figure has 
been used in this report. There is a 92% increase risk 
of melanoma of the skin associated with ever having 
been sunburned. See methodology annex for 
details. 
RISK FACTOR 5. SINGLE EPISODE OF 
SUNBURN & SUNBED USE 
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 The Irish Cancer Society conduct surveys on sunbed 
usage in Ireland. Results from 2007 found that 19% 
of people had used a sunbed at least once. There is 
a 20% increased risk of melanoma associated with 
ever having used a sunbed. 
 Due to the influence of sunburn (single episode and 
sunbed exposures) on non-melanoma skin cancer, 
we have also reported the attributable fractions on 
both basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC) in this section (see methodology 
annex for risk increases). However, it is important to 
note that these numbers are not included in the 
overall PAF analyses presented elsewhere in this 
report (i.e. for the “all cancer” group). Note also that 
pre-cancerous (‘in situ’) skin lesions are excluded for 
both melanoma and non-melanoma morphologies. 
 See Table 5 for PAFs and cases attributable to 
sunburn (single episode) and sunbed usage for BCC, 
SCC and melanoma. 
 Overall, 1.9% of all cancer (excluding NMSC) , i.e. 
the summary statistic presented for other risk 
factors in this report, were attributable to having a 
single episode of sunburn or use of sunbeds in 
Ireland in 2016. This figure relates to melanomas 
only. The estimated total of melanoma cases 
attributable to sunburn (ever sunburned) and 
sunbed exposure in Ireland in 2016 was 414. See 
Figure 5.1 for differences between male and female 
incidence.  
 It is worth considering that the UK reported that 
3.8% of all cancer and 86.5% of melanoma was 
attributable to UV exposure, which is likely a more 
accurate reflection of the burden of cancer resulting 
from UV exposure. Applying this PAF to our data 
would result in a doubling of cancer incidence 
relating to UV exposure. The UK estimated the UV-
attributable cases occurring in 2010 as the 
difference between the number observed and those 
that would have been expected with a theoretical-
minimum-risk exposure distribution, based on 
historical data from UK (estimated incidence rates 
for the generation of individuals born in 1903, 
resident in the South Thames region of England). 
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 This section describes the risk of cancer associated 
with exposure to ionizing radiations (including 
radon, diagnostic radiation and background 
radiation). These are defined by IARC has having 
sufficient evidence of carcinogenicity in humans and 
while such radiation is not necessarily a modifiable 
risk factor it is generally considered a source of 
preventable cancer cases (1). 
 
 
 
 
 
 
 
 
 
 
 
 These types of radiation are associated with an 
increased risk of 13 different types of cancer, as 
shown in Figure 6.1.  
 Radon is a natural radioactive gas that is produced 
as uranium and thorium (of which small amounts are 
found in soil and rock) decay. Radon is thought to be 
carcinogenic to the lung as a result of its production 
of reactive oxygen species which cause DNA 
damage. 
 Radon may be present in the home as a result of 
building construction practices. The National Radon 
Survey reported the mean indoor radon 
concentration as 89 Bq/m3 and that approximately a 
third of Ireland was classified as a high-radon area 
between 1992 and 1997 (2). See Figure 6.2 for risk of 
lung cancer associated with radon in Ireland (the % 
attributable risk shown is after smoking has been 
accounted for).  
 Background radiation includes cosmic radiation, 
gamma radiation from soils and radioactivity in food 
radiation and is associated with small increases in 
risks of many different cancer types (see 
methodology annex). Diagnostic radiation includes 
X-rays and radioactive tracers. 
RISK FACTOR 6. IONIZING RADIATION 
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 Cancer of the bladder is most significantly associated 
with diagnostic radiation, with 1.9% of cases being 
attributable. Leukaemia is most highly associated 
with background radiation, with 15.1% of leukaemia 
excluding chronic lymphocytic leukaemia and 9% of 
all leukaemia cases being attributable. 
 Overall, 1.1% of all cancer (excluding NMSC) was 
attributable to radiation in Ireland in 2016. The 
estimated total number of cancer cases attributable 
to ionizing radiation was 237. See Figure 6.3 for male 
and female comparisons. 
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How do these figures compare? 
The figures reported here are similar to those 
from the international literature. The UK 
reported a PAF of 1.9% for radiation, while 
France report PAFs of 1.2% and 0.7% for radon 
and diagnostic radiation respectively (3, 4).  
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  The WCRF and IARC state that high processed meat 
intake is associated with colorectal cancer and 
recommend that people eat little, if any, processed 
meat (1, 2). 
 Processed meat is defined by WCRF as meat that has 
been “transformed through salting, curing, 
fermentation, smoking or other processes to 
enhance flavour or improve preservation”. 
Processed meat can include ham, salami, bacon and 
some sausages such as frankfurters and chorizo. 
Minced meats such as fresh sausages may 
sometimes, though not always, count as processed 
meat (1). 
  Many of the preservation methods used to create 
processed meat are known to generate carcinogens 
(1). 
 
 
 According to NANS data, men and women in Ireland 
consume an average of 42.7 g and 23.9 g of 
processed meat per day respectively (3). 
 A recent review by WCRF concluded that, for adults 
in Europe, there is a 13% increased risk of 
developing colorectal cancer per 50 g/d increment 
(4). 
 Figure 7.1 shows the colon and rectal cancer cases 
attributable to processed meat intake in males and 
females. 
 Overall, 0.8% of all cancers (excluding NMSC) were 
attributable to high processed meat intake in Ireland 
in 2016. The estimated total of cancer cases 
attributable to processed meat intake in Ireland in 
2016 was 173. Figure 7.2 presents the difference in 
cases and PAF for all cancer related to processed 
meat for males and females. 
RISK FACTOR 7. PROCESSED MEAT INTAKE 
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 The link between meat intake and cancer has been 
widely covered in the media in recent times, with 
processed meat being categorised as being group 1 
carcinogens by IARC, i.e. in the same group as 
smoking and alcohol intake (2). Red meat has been 
deemed a ‘probable’ cause of cancer (or a Group 2a 
carcinogen) and therefore has not been included in 
this analysis. However, it is important to emphasise 
that IARC classifications describe the levels of 
scientific confidence that red and processed meat 
are linked to cancer but not how much cancer they 
cause. 
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How do these figures compare? 
The PAFs for processed meat intake and cancer 
incidence in Ireland were similar to those 
reported in the UK and US; 1.5% and 0.8% 
respectively (5, 6). 
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 Hormonal replacement therapy (HRT) is used to 
replace the female hormones that are no longer 
produced as a result of the menopause or medical 
conditions associated with reduced circulating 
female hormones. This can improve quality of life by 
relieving many of the symptoms of hormonal 
insufficiency/ menopause. There is also evidence to 
suggest that HRT can reduce risk of colorectal cancer 
and osteoporosis (1). 
  However, IARC report that there is sufficient 
evidence in humans for the carcinogenicity of 
combined oestrogen-progestogen menopausal 
therapy. HRT is associated with a small but 
measurable  increased risk of cancer of the breast 
and of the endometrium (1). 
 IARC indicate that hormone-receptor mediated 
responses are a likely mechanism for carcinogenesis 
by HRT. It is also thought that there is potential 
involvement   of  genotoxic   effects  of   HRT  or  the  
 
associated metabolic by-products including 
formation of DNA adducts and reactive oxygen 
species that damage DNA (1).  
 It is important to consider that HRT covers a wide 
range of treatments and that different forms, as well 
as duration of treatment, are associated with 
different risks and benefits. Benefits include reduced 
risk of some malignancies, osteoporosis and some 
cardiovascular issues (2). This was not accounted for 
in this analysis and the analyses did not seek to 
quantify the health benefits (including reducing 
incidence of some cancers) of HRT. It is 
recommended that individuals concerned about 
their cancer risk should seek the advice of a 
healthcare professional in relation to the balance of 
risks and benefits of HRT. 
 
RISK FACTOR 8. HORMONAL REPLACEMENT 
THERAPY 
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 Data from the Primary Care Reimbursement Service 
(PCRS) was obtained for 2006 and showed that 6.3% 
of women in the database were being prescribed 
some form of HRT. 
 Research on the relative risks of current versus never 
users of HRT shows that current users are 43% more 
likely to develop ovarian cancer and 66% more likely 
to develop breast cancer (see methodology annex).  
 Overall, 0.5% of all female cancers (excluding 
NMSC) were attributable to HRT usage in Ireland in 
2016. The estimated total of cancer cases 
attributable to HRT usage in Ireland in 2016 was 114. 
See Figure 8.1 for cancer type details. 
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How do these figures compare? 
The PAFs for HRT usage and cancer incidence 
were reported in France and Australia as 1.4% 
and 1.1% respectively (3, 4). Analysis in Alberta, 
Canada, in which potentially prevented as well as 
attributable cancers were calculated, reported 
2.7% of cancer being attributed to current usage 
of HRT and 0.3% of cancer incidence potentially 
prevented (5). 
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 IARC assess that there is sufficient evidence for the 
carcinogenicity of different types of oral 
contraceptives, including combined estrogen and 
progestogen oral contraceptives. Combined 
hormonal contraceptive use is associated with an 
increased risk of cancer of the breast and of the 
cervix for a period of time after use (1, 2). 
 Oral contraceptives are also associated with a 
decreased risk of other cancer types, including 
ovarian, colorectal and endometrial, which is not 
accounted for in this report. It is likely that the net 
effect of cancer cases attributable to oral 
contraceptive usage is close to neutral (2, 3). 
 The mechanisms through which oral contraceptives 
act as carcinogens are similar to those for HRT: 
through direct genotoxicity and receptor-mediated 
effects, including cell proliferation and 
differentiation (1). 
 Data from the PCRS was obtained for 2006 and 
showed that 20% of women in the database were 
being prescribed oral contraceptives. 
 Compared to women who have never used an oral 
contraceptive, current users are at a 90% and 21% 
higher risk of being diagnosed with cervical and 
breast cancers respectively (see methodology). 
 Overall, 0.5% of all female cancers (excluding 
NMSC) were attributable to oral contraceptive usage 
in Ireland in 2016. The estimate of total cancer cases 
attributable to oral contraceptive usage in Ireland in 
2016 was 114. See Figure 9.1 for cancer type details. 
 A more detailed analysis of oral contraceptive usage 
was carried out in Alberta, Canada in which 
potentially prevented, as well as attributable cancer 
cases were calculated. It was reported that 1.8% of  
 
 
cancer was attributable to, and 4.3% was potentially 
prevented by, using oral contraceptive (3). 
 
Note: Cervical cancer is largely attributable to HPV, however 
long-term use of oral contraceptives may increase the 
probability of the progression of HPV infection into cervical 
cancer. Therefore a proportion of cervical cancer is also 
attributable to women who contract HPV and are also taking 
certain types of oral contraceptives. 
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 The WCRF state there is convincing evidence that 
physical activity decreases the risk of colon cancer 
(1). They define physical activity as any movement 
that uses skeletal muscles and requires more energy 
than resting. 
 There are a number of ways in which physical 
activity is thought to reduce colon cancer. Physical 
activity results in body fat reduction and may have a 
beneficial effect on colorectal cancer risk through a 
reduction in insulin resistance and inflammation (1). 
 The 2007 SLAN report defined physical activity as 
low, moderate or high (see methodology annex for 
definitions). Overall, 71% of respondents had 
physical activity scores that fell within the moderate 
(47%) or high (24%) range (2).  
 A 10% reduction in relative risk of colon cancer is 
observed in persons with moderate or high 
compared to low levels of physical activity (see 
methodology). Our methodology did not seek to 
quantify the numbers of cancers prevented by 
having the moderate or high activity lifestyles 
common in our society. 
 3% of colon cancer cases are attributable to physical 
inactivity in Ireland. 
 Overall, the levels of inactivity in the SLAN report are 
associated with a 0.2% increased burden of all 
cancers (excluding NMSC) in 2016. The estimate of 
total cancer cases attributable to physical inactivity 
in Ireland in 2016 was 38. See Figure 10.1 for 
difference between male and female incidence. 
 
 The Health Service Executive Ireland recommend 
that adults get at least 30 minutes a day of moderate 
activity on 5 days a week (or 150 mins a week) (4). 
 With 71% of our population having moderate or high 
levels of activity we would expect to see a rise in 
cancer numbers if these levels of activity were to 
significantly decline across the population over an 
extended period.  
 Breast, rectal and endometrial cancer may be 
additional cancers included in future analysis for this 
risk factor, subject to clarification of the strength of 
evidence for the role of physical inactivity in these 
cancers. The promotion of physical activity is likely 
to be an effective strategy in the primary prevention 
of these commonly diagnosed cancer types. 
 
 
RISK FACTOR 10. LACK OF PHYSICAL 
ACTIVITY 
How do these figures compare? 
The PAF for physical inactivity and cancer 
incidence in the UK was 0.5% (3). 
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  When organic matter is burned, airborne 
particulate pollution is emitted. According to IARC, 
there is convincing evidence that long-term 
exposure to this air pollution causes lung cancer (1). 
 Ambient air pollution may act as a carcinogen 
through mutagenicity, genotoxicity and male germ 
cell effects (1). 
  The Environmental Protection Agency (EPA) 
measures air quality in Ireland. In 2006, the EPA 
measured fine particulate matter (PM2.5), an 
indicator of man-made emissions, in Cork city only 
and reported the annual mean as 9 PM2.5 (2). 
 Although the measurements represent Cork city 
rather than national exposure, the EPA have since 
started monitoring PM2.5 concentrations at nine 
different sites and in 2009 these measurements 
were similar across zones. All observed 
concentrations were below the EU annual limit 
value. See EPA reports for further details (3). 
 The relative risk for lung cancer associated with 
PM2.5 is 1.09, i.e. there is a 9% increase in risk per 10 
µg/m3 in exposure to PM2.5 (see methodology). 
 7.5% of lung cancer cases (after smoking is 
accounted for) in Ireland would be attributable to 
exposure to airborne PM2.5. 
 Overall, 0.2% of all cancer (excluding NMSC) were 
attributable to PM2.5 exposure, in Ireland in 2016. 
The estimate of total cancer cases attributable to 
PM2.5 from pollution in Ireland in 2016 was 36. See 
Figure 11.1 for difference between male and female 
incidence. 
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RISK FACTOR 11. FINE PARTICULATE AIR 
POLLUTION (PM2.5) 
How do these figures compare? 
In relation to air pollution (fine particulate 
matter) and cancer incidence, France and the 
UK reported PAFs of 0.4% and 1% (4, 5). 
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Projections of all cancer cases (excluding NMSC) attributable to 
smoking, overweight/obesity and alcohol intake were modelled to 
2035.  
Projections of cancer cases 
attributable to smoking. 
 Figure P.1 presents male and female projections to 
2035 for all cancer cases (excluding NMSC) 
attributable to smoking. It should be noted that 
these projections do not include exposure to passive 
smoking and do not account for recent trends in the 
use of e-cigarettes, and further investigation will be 
required when more information becomes available. 
 By 2035, it is estimated that, if smoking rates remain 
unchanged, 2,897 and 1,765 male and female cancer 
cases will be attributable annually to smoking. This 
represents a 78% increase for males and a 53% 
increase for females (68% increase overall) 
compared with 2016 caseloads attributable to 
smoking. In the 10-year period ending in 2035, it is 
estimated that a cumulative total of 42,336 cancer 
cases will be attributable to smoking. 
 In relation to smoking, a target scenario was then 
modelled where the percentage of smokers will be 
reduced to 5% by 2025 based on “Tobacco Free 
Ireland 2025” goals (1). 
 If the percentage of smokers in Ireland were reduced 
to 5% of the population, it is estimated there would 
be over 1,000 fewer cancer cases a year by 2035 as 
a result (Figure P.1), compared with caseloads 
attributable to smoking if smoking prevalence 
remained unchanged. This would translate to a 
smaller increase (5% for males, 18% for females and 
28% overall) in cancer incidence attributable to 
smoking, compared with the much larger increases 
expected if smoking prevalence remained 
unchanged. 
Projections of cancer cases 
attributable to overweight and 
obesity. 
 By 2035, it is estimated that 848 and 940 male and 
female cancer cases will be attributable to 
overweight and obesity yearly (Figure P.2). This 
represents a 43% increase for males and a 100% 
increase for females (69% increase overall) 
compared with 2016 caseloads attributable to 
overweight and obesity. In the 10-year period 
ending in 2035, it is estimated that 16,267 cancer 
cases will be attributable to these factors. 
 In the case of BMI, we applied two scenarios; these 
were based on the prevalence of overweight and 
obesity being either reduced or increased by 5% 
each.  
 If the percentages of individuals in Ireland who are 
overweight and obese both decreased by 5%, it is 
estimated that there would be a 21% increase for 
males and a 68% increase for females (42% increase 
overall) in numbers attributable to high BMI by 
SCENARIO PROJECTIONS  
SMOKING, OVERWEIGHT & OBESITY, & 
ALCOHOL 
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2035, compared with 2016 caseloads attributable to 
overweight and obesity (Figure P.2). This would be a 
substantially smaller increase in cases attributable 
to high BMI than if prevalence of high BMI remained 
unchanged. 
 If the percentages of individuals in Ireland who are 
overweight and obese both increased by 5%, it is 
estimated that there would be a 65% increase for 
males and a 128% increase for females (93% 
increase overall) by 2035, compared with 2016 
caseloads attributable to these factors (Figure P.2). 
This would be a substantially greater increase in 
cases attributable to high BMI than if prevalence of 
high BMI remained unchanged. 
Projections of cancer cases 
attributable to alcohol intake. 
 Figure P.3 presents projected incidence of cancer 
attributed to alcohol intake.  
 By 2035, it is estimated that 394 and 457 male and 
female cancer cases will be attributable to alcohol 
intake yearly at the current rate of consumption. 
This represents a 37% increase for males and a 110% 
increase for females (69% increase overall) 
compared with 2016 caseloads attributable to 
alcohol intake. In the 10-year period ending in 2035, 
it is estimated that 7,741 cancer cases will be 
attributable to alcohol intake. 
 As well as projecting the cancer incidence 
attributable to alcohol intake with the current PAF, 
a scenario involving a decrease in the prevalence of 
moderate and heavy drinkers was also modelled, 
reflecting decreasing trends in alcohol usage (see 
methodology annex for details). 
 If the percentages of individuals in Ireland who are 
moderate and heavy drinkers both decreased by 5%, 
it is estimated that there would be no increase (a 
0.1% decrease) in alcohol-attributable cases for 
males but a 79% increase for females (34% increase 
overall) by 2035, compared with 2016 caseloads 
attributable to moderate or heavy alcohol 
consumption (Figure P.3). This would represent a 
substantial improvement over projections based on 
no change in alcohol consumption. 
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Figure P.1. Cancer cases (all excluding NMSC) attributable to smoking in 2016 and in 2035, 
with current smoking PAF and the PAF if the percentage of current smokers was reduced to 
5%, by sex. 
 
*excludes ex-smokers 
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Figure P.2. Cancer cases (all excluding NMSC) attributable to overweight and obesity in 
2016 and in 2035, with current PAF and PAF if the prevalence of overweight and obesity 
was either reduced or increased by 5%, by sex. 
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Figure P.3. Cancer cases (all excluding NMSC) attributable to alcohol intake in 2016 and in 
2035, with current PAF and PAF if the prevalence of moderate and heavy alcohol intake was 
reduced by 5%, by sex.  
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 Summary 
 In 2016, an estimated 29.3% (6,238) of all cancer 
cases (excluding NMSC) were attributable to the 11 
modifiable risk factors examined in this study; 
 Smoking 
 Infection 
 Overweight and obesity 
 Alcohol intake  
 Single-episode sunburn, and sunbed usage 
 Ionizing radiation 
 Processed meat intake 
 Oral contraceptives 
 Hormone replacement therapy 
 Lack of physical activity  
 Air pollution (due to fine particulate matter). 
 UK based research on the proportion of cancer 
attributable to modifiable risk factors reported 
37.7% of cancer in 2015 as being attributable to 14 
different modifiable lifestyle risk factors (1), so our 
findings are similar given our narrower range of 
focus on factors and the conservative, high 
stringency of the attributable fractions we 
employed.  
 The United States reported 42% of cancer as being 
potentially preventable, with the higher number 
largely being due to different inclusion criteria 
utilised (2). That study included additional dietary 
factors, such as low fruit and vegetables, low fibre, 
low calcium, and consumption of red meat.  
 Smoking, overweight and obesity, and infections 
were the top 3 risk factors in Ireland, together 
accounting for about 21% of all cancers. 
 
 
 
 Smoking (including passive smoking in the home) 
was the risk factor accounting for the highest 
attributable proportion of all cancer (excluding 
NMSC) cases, at 13%. Brown et al. reported 14.6% 
and 15.1% of cancer as being attributable to smoking 
in 2015 in Northern Ireland and the wider UK 
respectively (1). 
 The estimates we have arrived at are most likely 
quite conservative. Although the 10-year lag period 
has been determined as most suitable for use in 
evaluating burden of disease, there is evidence that 
a longer latency period is required to determine the 
cancer incidence attributable to some factors, such 
as tobacco smoking. As prevalence of smoking is 
decreasing, the chosen lag period may yield an 
underestimate. However, the impact may be 
minimal, for example the UK reported a difference 
of only 1 percentage point when using 20-year 
latency compared with 10 year latency period (1). 
This supports the use of higher quality, more recent 
data with a 10-year latency period in Ireland.  
 5.0% of cancer cases (excluding NMSC) were 
attributable to being overweight or obese; this 
equates to 1,061 cancer cases in Ireland in 2016. 
Brown et al. reported that 6.3% of cancer incidence 
in the UK was attributable to overweight and obesity 
(1).  
 A number of carcinogenic infection types were 
grouped together, and overall 3.6% of cancer 
(excluding NMSC) incidence in Ireland was 
attributable to these infections. In the UK, 3.6% of 
cancer incidence in 2015 was reported attributable 
to infection (1). The burden of cancer attributable to 
infection has previously been reported as higher in 
Ireland compared to the UK (3). It should be noted 
that for certain infection types, including H. pylori, 
there is no adequate data on prevalence in Ireland. 
As a result, either pre-calculated PAFs or data from 
KEY DISCUSSION POINTS 
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Northern Ireland were used an alternative. Further 
national information on the prevalence of infection 
would strengthen our understanding of this 
evidence.  
 Public awareness of modifiable risk factors for 
cancer needs to be addressed. According to recent 
Irish surveys, only 32% of people are aware that 
obesity is a risk factor for cancer (4), 75% of Irish 
adults don’t know what HPV is and 56% of Irish 
adults are not aware that HPV infections can cause 
cancer (5).  
 Lung cancer had the highest number of cases 
attributable to modifiable risk factors in both males 
and females, followed by colon and stomach cancer 
in males and breast and cervical cancer in females. 
This is consistent with international findings (1, 2).  
 The differences between males and females in 
cancer cases attributable to modifiable risk factors 
have been highlighted in each risk factor section, 
with males having higher PAFs for smoking and 
processed meat intake, and females having higher 
PAFs for overweight and obesity, infection and 
alcohol intake. 
 These are largely modifiable risk factors meaning 
that at least 29.3% of cancer incidence in Ireland is 
potentially preventable. The prevention of cancer 
should be the first step in cancer control, in terms of 
reducing the burden on both patients and health 
services (6). 
 It is important to consider that this 29.3% is an 
underestimate of preventable cancer in Ireland, for 
example: 
 The risk associated with occupation was not 
accounted for here and should be examined in 
future research. In the UK, 3.8% of cancer cases 
were attributable to occupation-related risk.  
 Everyday exposure to ultraviolet radiation (UVR) 
was not included; only sunburn history (single 
episode) and sunbed usage. 
 Between 2026 and 2035 (inclusive), it is estimated 
that a cumulative total of 66,343 cancer cases will be 
attributable to smoking, overweight and obesity, 
and alcohol intake if prevalence of these risk factors 
remains unchanged. 
 Assuming prevalence remains the same, it is 
estimated that in 2035 there will be 4,661 cancer 
cases attributable to smoking, 1,788 attributable to 
overweight and obesity, and 851 attributable to 
alcohol intake. 
 Several of the risk factors in this report are 
associated with not only cancer but a range of other 
diseases, including heart disease, cerebrovascular 
disease, diabetes and chronic obstructive pulmonary 
disease.  Therefore policies to reduce the prevalence 
of these modifiable risk factors should consider the 
wider impact on public health. 
 
Limitations and considerations 
 PAF estimates are dependent on the quality of the 
data from which they are calculated. When selecting 
the relative risk for each cancer and risk-factor 
combination, differences in cancer risk among 
subpopulations need to be considered. 
 Furthermore, data on exposure to risk factors come 
from multiple sources and not all of these may be 
nationally representative. There needs to be more 
comprehensive and routinely collected data on 
exposure to modifiable health-risk factors in Ireland. 
The routine monitoring of health behaviours at a 
population level is necessary to plan and evaluate 
the impact of effective cancer prevention strategies. 
 The limitation above is a particular issue in relation 
to prevalence of infection types. As described 
previously, a variety of information sources were 
used as substitutes in the absence of nationally 
representative data including Northern Ireland data 
for H. pylori and pre-calculated PAFs for HPV and 
EBV (as per Brown et al. (1)). The data used to 
estimate H. pylori prevalence is from the 1980s and 
therefore to overcome this limitation we aimed to 
reflect changes in treatment and prevalence over 
time by applying an annual mean decrease based on 
European trends. See methodology annex for 
further details. 
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 The biological latency period between exposure to a 
risk factor and development of cancer is another 
important consideration. This is sometimes 
unknown and there can be large variation in 
estimates depending on the risk factor and cancer 
type. Given the lack of data on this and in order to 
be consistent with other analysis in this area, a 10-
year lag time was selected for all risk factors (1). 
 Estimates of PAFs in this report are conservative as 
we used stringent criteria, requiring un-ambiguous 
consensus assertions by relevant professional 
bodies as to carcinogenicity, and calculations were 
based only on cancer / risk-factor combinations with 
the highest levels of evidence (“convincing” or 
“sufficient”).  
 These estimates are also conservative due to the 
risks associated with occupation and everyday sun 
exposure not being accounted for here, as well as 
issues in determining latency periods, which should 
be addressed in future investigations.  
 In 2013, Laffoy et al. published research on cancer 
incidence due to alcohol intake in Ireland and 
estimated PAFs of 4.7% in males and 4.2% in females 
(7). The differences between the PAFs reported here 
and those previously published are explained by 
methodological differences. For example, Laffoy et 
al. used SLAN data and adjusted for self-reporting. In 
this analysis, NANS data and updated relative risks 
based on a 2015 meta-analysis were applied. 
Furthermore, differences in the cancer site inclusion 
criteria between the two studies also contribute, but 
to a lesser extent, to differences between these 
studies in their findings re alcohol intake.  
 This analysis reports 0.2% of all cancer (excluding 
NMSC) as attributable to physical inactivity. This is a 
conservative estimate and is lower than the UK 
figure of 0.5% (1). A more sophisticated analysis on 
physical inactivity is warranted in which factors such 
as the time and intensity of physical activity are also 
taken into account.  It is also important to point out 
that these figures are based on the majority of our 
population being moderately or highly active 
(known to reduce the incidence of a number of 
malignancies).  Hence, if activity rates declined, we 
might expect a disproportionate increase in cancer 
rates commensurate with reduction in the anti-
carcinogenic effect of this type of lifestyle. 
 This report focuses on the fraction of cancer 
attributable to sunburn history (ever sunburned) 
and sunbed usage only, and does not include the 
fraction attributable to everyday sun exposure, due 
to lack of data on Irish sun exposure behaviours. 
Given that over-exposure to the sun is the single 
biggest cause of cancer (if the generally less 
dangerous non-melanoma skin cancers are also 
included), further analysis needs to be undertaken 
to establish its true impact.  
 This analysis only includes information on risk 
factors increasing the risk of cancer and does not 
account for how certain risk factors, such as oral 
contraceptive and HRT usage, can potentially reduce 
certain cancer types and other disease. 
 The analysis does not attempt to take into account 
the potential cancer-causing synergies of multiple 
factors taken together.  For example, smoking and 
HPV infection synergise to increase the likelihood of 
head and neck cancers.  Smoking and radon gas 
exposure synergise to give greater likelihood of lung 
cancer than simply adding the PAFs for each factor 
together. 
 Subgroup analysis in different socio-demographic 
groups is warranted due to the different rates of 
smoking, alcohol use and obesity evident in different 
communities. However, this is not possible at this 
time due to lack of relevant information for many of 
the risk factors included in this analysis. Prevention 
strategies need to be mindful of various groups in 
our society that face greater burdens from particular 
types of cancer.  
 There are also likely to be differences between rural 
and urban areas, which should be considered in 
future investigations on risk factor prevalence. 
 This analysis relates to primary cancer incidence in 
Ireland, and there is no estimate for the contribution 
of these modifiable risk factors to the risk of cancer 
recurrence. 
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Strengths 
 Cancer type and modifiable risk factors were 
included using definitions by IARC or WCRF as having 
“sufficient” (IARC) or “convincing” (WCRF) evidence 
of a causal association. 
 The approach taken is consistent across all risk 
factors and all cancer types and can be replicated in 
future analysis. 
 The analysis is comparable to similar work carried 
out in different countries, including the UK (1). 
 This analysis has involved the use of NCRI data on 
population-level cancer incidence. This is high-
quality, complete data (8). 
 The risk factors selected are largely modifiable and 
amenable to strategic policy responses and 
initiatives. 
 This analysis provides context-specific evidence; 
such information has not previously been available 
in Ireland. 
 Cancer cases (excluding NMSC) attributable to 
smoking (excluding passive smoking), overweight 
and obesity, and alcohol intake were modelled to 
2035. These projections should be considered by 
policymakers and there needs to be an effort to 
ensure that the projected increases are not realised. 
 
Recommendations 
 Out of the 11 risk factors examined, smoking, 
overweight and obesity, and infection are the 
biggest risk factors for cancer incidence in Ireland. 
These risk factors need to continue to be targeted by 
public health representatives and policymakers. 
 The findings in this report should be used for future 
health-related policy planning. Efforts to ensure that 
projected increases in cancer incidence are not 
realised are essential. 
 Comprehensive and routine collection of data on 
exposure to risk factors in Ireland needs to be 
considered in the future. 
 Analyses in this report should be repeated in future 
years to ensure regular monitoring and to assess the 
impact of policy change and intervention on public 
health outcomes. 
 Research studies on specific risk factors using more 
sophisticated methodology should be considered 
both locally and internationally.  
 Future work in this area should examine outcomes 
including the impact on mortality, quality of life, etc. 
in addition to cancer incidence. 
 The impact of risk factors on quality of life should be 
considered in future analyses. This is an important 
question, as cancer is increasingly described as a 
chronic disease, and impacts on quality of life will 
depend on the specific types of cancer and 
treatments involved. 
 Economic impacts of modifiable risk factors for 
cancer should also be considered. The economic 
burden of cancer for the health services, patients 
and their families, and society at large are 
substantial. This burden will likely increase in the 
coming years as novel, more expensive treatments 
become available and the number of people living 
with and beyond cancer increases. The NCRI will be 
compiling a follow-up report estimating the 
economic burden of cancer in Ireland attributable to 
modifiable risk factors, and that report’s findings 
should be considered by policymakers. 
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